SEI Investments
OMED

SEI Investments’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

SEI Investments’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-132
Closed -$1K – 3492
2017
Q1 		$1K Hold
132
– – ﹤0.01% 2886
2016
Q4 		$1K Hold
132
– – ﹤0.01% 2892
2016
Q3 		$2K Buy
+132
New +$1.54K ﹤0.01% 2704

Other funds holding OMED

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SEI Investments's OMED Position: Q2 2017 in Review

SEI Investments sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2017, closing a stake of 132 shares — an estimated $1K sold.

SEI Investments first reported a position in OMED in Q3 2016 and held it in 3 quarters. The position peaked at $2K in Q3 2016. 68 funds tracked by Wall St. Rank hold OMED as of Q2 2017.

  • SEI Investments reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • SEI Investments sold 132 OncoMed Pharmaceuticals, Inc. shares in Q2 2017, an estimated $1K.
  • SEI Investments first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2016 and held it in 3 quarters.
  • SEI Investments's OncoMed Pharmaceuticals, Inc. position peaked at $2K in Q3 2016.
  • 68 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2017.

Based on SEI Investments's 13F filing for Q2 2017, filed 31 Jul 2017.